<p>CryoPort（納斯達克代碼：CYRX - 獲取免費報告）在週三發佈的報告中，Needham &amp; Company LLC 將其目標股價從 12.00 美元上調至 13.00 美元，Benzinga 報道。該公司目前對該股票給予 “買入” 評級。Needham &amp; Company LLC 的目標股價指向該公司當前價格的潛在上漲幅度為 53.12%。</p>
<p>其他股票研究分析師也對該股票發佈了研究報告。瑞銀集團將 CryoPort 的目標股價從 11.00 美元上調至 12.50 美元，並在 11 月 5 日的報告中給予該股票 “買入” 評級。Weiss Ratings 在 12 月 29 日的研究報告中重申了對 CryoPort 的 “賣出（d+）” 評級。八位研究分析師對該股票給予了買入評級，一位給予了持有評級，一位給予了賣出評級。根據 MarketBeat 的數據，該股票的共識評級為 “適度買入”，平均目標股價為 12.94 美元。</p>
<p><strong>獲取我們關於 CYRX 的最新報告</strong></p>
<h2>CryoPort 股價上漲 3.4%</h2>
<p>CryoPort 股票在週三開盤價為 8.49 美元。CryoPort 的一年低點為 4.58 美元，一年高點為 11.45 美元。該公司的 50 日移動平均價格為 9.51 美元，200 日移動平均價格為 9.41 美元。公司的債務與股本比率為 0.40，流動比率為 15.77，速動比率為 15.01。該股票的市值為 4.2509 億美元，市盈率為 7.26，貝塔值為 1.69。</p>
<p>CryoPort（納斯達克代碼：CYRX - 獲取免費報告）最後一次發佈財報是在 3 月 3 日，報告顯示該公司每股收益（EPS）為（0.27）美元，低於共識預期的（0.19）美元，差額為（0.08）美元。該公司在該季度的收入為 4545 萬美元，而共識預期為 4292 萬美元。CryoPort 的股本回報率為負 11.07%，淨利潤率為 35.57%。平均而言，股票分析師預測 CryoPort 在當前財政年度將發佈 -0.99 的每股收益。</p>
<h2>CryoPort 的內部交易</h2>
<p>在相關消息中，董事 Ramkumar Mandalam 於 12 月 10 日星期三出售了 11,570 股該股票。該股票的平均售價為 9.99 美元，總價值為 115,584.30 美元。交易完成後，該董事直接持有該公司 80,758 股股票，價值約為 806,772.42 美元。這代表了他們持有的股票減少了 12.53%。該出售在與 SEC 的法律文件中披露，可以通過此鏈接訪問。內部人士持有該公司 10.10% 的股票。</p>
<h2>機構投資者對 CryoPort 的看法</h2>
<p>幾家機構投資者和對沖基金最近修改了對 CYRX 的持股。Assenagon Asset Management S.A. 在第三季度將其在 CryoPort 的持股增加了 37.4%。Assenagon Asset Management S.A. 現在擁有 1,498,774 股該公司的股票，價值 1,420.8 萬美元，此前在該期間內購買了額外的 408,263 股。SG Americas Securities LLC 在第三季度將其在 CryoPort 的持股增加了 663.2%。SG Americas Securities LLC 現在擁有 127,280 股該公司的股票，價值 120.7 萬美元，此前在上個季度購買了額外的 110,602 股。Y Intercept Hong Kong Ltd 在第二季度購買了 CryoPort 的新股份，價值約為 29.2 萬美元。Bullseye Asset Management LLC 在第二季度將其在 CryoPort 的持股增加了 23.0%。Bullseye Asset Management LLC 現在擁有 260,168 股該公司的股票，價值 194.1 萬美元，此前在上個季度獲得了額外的 48,605 股。最後，Thematics Asset Management 在第二季度將其在 CryoPort 的持股增加了 12.8%。Thematics Asset Management 現在擁有 1,914,885 股該公司的股票，價值 1,428.5 萬美元，此前在上個季度獲得了額外的 216,937 股。對沖基金和其他機構投資者持有該公司 92.90% 的股票。</p>
<h2>CryoPort 公司簡介</h2>
<p>（獲取免費報告）</p>
<p>CryoPort, Inc（納斯達克代碼：CYRX）是生命科學行業温控物流解決方案的全球提供商。該公司專注於關鍵生物材料的低温運輸，支持細胞和基因療法、生物製品、疫苗和生殖醫學的開發、臨牀測試和商業化。通過提供端到端的供應鏈管理，CryoPort 幫助確保温度敏感產品從起點到目的地的完整性和可行性。</p>
<p>CryoPort 的產品組合包括專有的低温乾貨運輸工具、先進的主動和被動熱包裝以及實時數據監測平台。</p>
<h2>另見</h2>
<ul>
<li>五隻我們更看好的股票，勝過 CryoPort</li>
<li>新發現的富銅 “克拉肯” 區</li>
<li>埃隆警告 “美國破產”。特朗普的計劃在此。</li>
<li>美國的 1776 再次發生</li>
<li>你可能想更換財務顧問的 3 個跡象</li>
<li>白銀的擠壓正在收緊 - 機會正在形成</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q1lSWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q1lSWA"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 CryoPort 嗎？</h2>
<p>在你考慮 CryoPort 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而 CryoPort 並不在名單上。</p>
<p>雖然 CryoPort 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

CYRX

<p>Needham & Company LLC 將 CryoPort (NASDAQ:CYRX) 的目標股價從 12.00 美元上調至 13.00 美元，維持 “買入” 評級。這表明與當前價格相比，潛在上漲幅度為 53.12%。包括瑞銀集團在內的其他分析師也給予了積極評級。CryoPort 的股票開盤價為 8.49 美元，市值為 4.2509 億美元。該公司報告的收入為 4545 萬美元，但未達到每股收益預期。機構投資者持有 92.90% 的股份，顯示出對該公司的強烈興趣</p>

<p>CryoPort (NASDAQ:CYRX - Get Free Report) had its price target raised by stock analysts at Needham &amp; Company LLC from $12.00 to $13.00 in a report released on Wednesday,Benzinga reports. The firm currently has a &#34;buy&#34; rating on the stock. Needham &amp; Company LLC's price target points to a potential upside of 53.12% from the company's current price.</p>
<div class="lb-trans"><p>CryoPort（納斯達克代碼：CYRX - 獲取免費報告）在週三發佈的報告中，Needham &amp; Company LLC 將其目標股價從 12.00 美元上調至 13.00 美元，Benzinga 報道。該公司目前對該股票給予 “買入” 評級。Needham &amp; Company LLC 的目標股價指向該公司當前價格的潛在上漲幅度為 53.12%。</p>
</div><p>Other equities research analysts have also issued research reports about the stock. UBS Group raised their target price on shares of CryoPort from $11.00 to $12.50 and gave the stock a &#34;buy&#34; rating in a report on Wednesday, November 5th. Weiss Ratings reaffirmed a &#34;sell (d+)&#34; rating on shares of CryoPort in a research report on Monday, December 29th. Eight research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $12.94.</p>
<div class="lb-trans"><p>其他股票研究分析師也對該股票發佈了研究報告。瑞銀集團將 CryoPort 的目標股價從 11.00 美元上調至 12.50 美元，並在 11 月 5 日的報告中給予該股票 “買入” 評級。Weiss Ratings 在 12 月 29 日的研究報告中重申了對 CryoPort 的 “賣出（d+）” 評級。八位研究分析師對該股票給予了買入評級，一位給予了持有評級，一位給予了賣出評級。根據 MarketBeat 的數據，該股票的共識評級為 “適度買入”，平均目標股價為 12.94 美元。</p>
</div><p><strong>Get Our Latest Report on CYRX</strong></p>
<div class="lb-trans"><p><strong>獲取我們關於 CYRX 的最新報告</strong></p>
</div><h2>CryoPort Trading Up 3.4%</h2>
<div class="lb-trans"><h2>CryoPort 股價上漲 3.4%</h2>
</div><p>CryoPort stock opened at $8.49 on Wednesday. CryoPort has a 1 year low of $4.58 and a 1 year high of $11.45. The firm's 50 day moving average price is $9.51 and its 200-day moving average price is $9.41. The company has a debt-to-equity ratio of 0.40, a current ratio of 15.77 and a quick ratio of 15.01. The stock has a market cap of $425.09 million, a P/E ratio of 7.26 and a beta of 1.69.</p>
<div class="lb-trans"><p>CryoPort 股票在週三開盤價為 8.49 美元。CryoPort 的一年低點為 4.58 美元，一年高點為 11.45 美元。該公司的 50 日移動平均價格為 9.51 美元，200 日移動平均價格為 9.41 美元。公司的債務與股本比率為 0.40，流動比率為 15.77，速動比率為 15.01。該股票的市值為 4.2509 億美元，市盈率為 7.26，貝塔值為 1.69。</p>
</div><p>CryoPort (NASDAQ:CYRX - Get Free Report) last issued its earnings results on Tuesday, March 3rd. The company reported ($0.27) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.19) by ($0.08). The firm had revenue of $45.45 million during the quarter, compared to the consensus estimate of $42.92 million. CryoPort had a negative return on equity of 11.07% and a net margin of 35.57%. On average, equities analysts predict that CryoPort will post -0.99 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>CryoPort（納斯達克代碼：CYRX - 獲取免費報告）最後一次發佈財報是在 3 月 3 日，報告顯示該公司每股收益（EPS）為（0.27）美元，低於共識預期的（0.19）美元，差額為（0.08）美元。該公司在該季度的收入為 4545 萬美元，而共識預期為 4292 萬美元。CryoPort 的股本回報率為負 11.07%，淨利潤率為 35.57%。平均而言，股票分析師預測 CryoPort 在當前財政年度將發佈 -0.99 的每股收益。</p>
</div><h2>Insider Transactions at CryoPort</h2>
<div class="lb-trans"><h2>CryoPort 的內部交易</h2>
</div><p>In related news, Director Ramkumar Mandalam sold 11,570 shares of the stock in a transaction that occurred on Wednesday, December 10th. The stock was sold at an average price of $9.99, for a total value of $115,584.30. Following the completion of the transaction, the director directly owned 80,758 shares in the company, valued at approximately $806,772.42. This represents a 12.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 10.10% of the company's stock.</p>
<div class="lb-trans"><p>在相關消息中，董事 Ramkumar Mandalam 於 12 月 10 日星期三出售了 11,570 股該股票。該股票的平均售價為 9.99 美元，總價值為 115,584.30 美元。交易完成後，該董事直接持有該公司 80,758 股股票，價值約為 806,772.42 美元。這代表了他們持有的股票減少了 12.53%。該出售在與 SEC 的法律文件中披露，可以通過此鏈接訪問。內部人士持有該公司 10.10% 的股票。</p>
</div><h2>Institutional Investors Weigh In On CryoPort</h2>
<div class="lb-trans"><h2>機構投資者對 CryoPort 的看法</h2>
</div><p>Several institutional investors and hedge funds have recently modified their holdings of CYRX. Assenagon Asset Management S.A. increased its holdings in CryoPort by 37.4% during the 3rd quarter. Assenagon Asset Management S.A. now owns 1,498,774 shares of the company's stock worth $14,208,000 after purchasing an additional 408,263 shares during the period. SG Americas Securities LLC grew its position in shares of CryoPort by 663.2% during the third quarter. SG Americas Securities LLC now owns 127,280 shares of the company's stock worth $1,207,000 after buying an additional 110,602 shares in the last quarter. Y Intercept Hong Kong Ltd purchased a new stake in shares of CryoPort during the second quarter worth approximately $292,000. Bullseye Asset Management LLC lifted its stake in CryoPort by 23.0% in the second quarter. Bullseye Asset Management LLC now owns 260,168 shares of the company's stock worth $1,941,000 after acquiring an additional 48,605 shares during the last quarter. Finally, Thematics Asset Management lifted its stake in CryoPort by 12.8% in the second quarter. Thematics Asset Management now owns 1,914,885 shares of the company's stock worth $14,285,000 after acquiring an additional 216,937 shares during the last quarter. Hedge funds and other institutional investors own 92.90% of the company's stock.</p>
<div class="lb-trans"><p>幾家機構投資者和對沖基金最近修改了對 CYRX 的持股。Assenagon Asset Management S.A. 在第三季度將其在 CryoPort 的持股增加了 37.4%。Assenagon Asset Management S.A. 現在擁有 1,498,774 股該公司的股票，價值 1,420.8 萬美元，此前在該期間內購買了額外的 408,263 股。SG Americas Securities LLC 在第三季度將其在 CryoPort 的持股增加了 663.2%。SG Americas Securities LLC 現在擁有 127,280 股該公司的股票，價值 120.7 萬美元，此前在上個季度購買了額外的 110,602 股。Y Intercept Hong Kong Ltd 在第二季度購買了 CryoPort 的新股份，價值約為 29.2 萬美元。Bullseye Asset Management LLC 在第二季度將其在 CryoPort 的持股增加了 23.0%。Bullseye Asset Management LLC 現在擁有 260,168 股該公司的股票，價值 194.1 萬美元，此前在上個季度獲得了額外的 48,605 股。最後，Thematics Asset Management 在第二季度將其在 CryoPort 的持股增加了 12.8%。Thematics Asset Management 現在擁有 1,914,885 股該公司的股票，價值 1,428.5 萬美元，此前在上個季度獲得了額外的 216,937 股。對沖基金和其他機構投資者持有該公司 92.90% 的股票。</p>
</div><h2>CryoPort Company Profile</h2>
<div class="lb-trans"><h2>CryoPort 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>CryoPort, Inc NASDAQ: CYRX is a global provider of temperature-controlled logistics solutions for the life sciences industry. The company specializes in cryogenic shipping for critical biological materials, supporting the development, clinical testing and commercialization of cell and gene therapies, biologics, vaccines and reproductive medicine. By offering end-to-end supply chain management, CryoPort helps ensure the integrity and viability of temperature-sensitive products from point of origin to destination.</p>
<div class="lb-trans"><p>CryoPort, Inc（納斯達克代碼：CYRX）是生命科學行業温控物流解決方案的全球提供商。該公司專注於關鍵生物材料的低温運輸，支持細胞和基因療法、生物製品、疫苗和生殖醫學的開發、臨牀測試和商業化。通過提供端到端的供應鏈管理，CryoPort 幫助確保温度敏感產品從起點到目的地的完整性和可行性。</p>
</div><p>CryoPort's product portfolio includes proprietary cryogenic dry shippers, advanced active and passive thermal packaging, and real-time data monitoring platforms.</p>
<div class="lb-trans"><p>CryoPort 的產品組合包括專有的低温乾貨運輸工具、先進的主動和被動熱包裝以及實時數據監測平台。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另見</h2>
</div><ul>
<li>Five stocks we like better than CryoPort</li>
<li>New Copper-Rich “Kraken” Zone Discovered</li>
<li>Elon Warns “America Is Broke”. Trump’s Plan Inside.</li>
<li>America’s 1776 happening again</li>
<li>3 Signs You May Want to Switch Financial Advisors</li>
<li>Silver's squeeze is tightening - opportunity forming</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 CryoPort</li>
<li>新發現的富銅 “克拉肯” 區</li>
<li>埃隆警告 “美國破產”。特朗普的計劃在此。</li>
<li>美國的 1776 再次發生</li>
<li>你可能想更換財務顧問的 3 個跡象</li>
<li>白銀的擠壓正在收緊 - 機會正在形成</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q1lSWA" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&amp;Symbol=CYRX"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in CryoPort Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 CryoPort 嗎？</h2>
</div><p>Before you consider CryoPort, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮 CryoPort 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CryoPort wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而 CryoPort 並不在名單上。</p>
</div><p>While CryoPort currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 CryoPort 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Needham & Company LLC 預測 CryoPort（NASDAQ:CYRX）股票將迎來強勁的價格上漲